Original Source(s)
Related Content
FDA Expands CAPVAXIVE Pediatric Use
Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.
June 18, 2026
-
2 min
Beta-2 Agonists Tied to ASD Risk?
Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.
June 24, 2026
-
4 min